When to use cytotoxic drugs in rheumatoid arthritis.
D000936:Antigen-Antibody Complex; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007258:Informed Consent; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D012217:Rheumatoid Factor / Q000096:biosynthesis; D013583:Synovial Membrane / Q000276:immunology; D013852:Thiotepa / Q000627:therapeutic use
D000936:Antigen-Antibody Complex; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds; D002699:Chlorambucil; D003520:Cyclophosphamide; D012217:Rheumatoid Factor; D013852:Thiotepa; D015122:Mercaptopurine; D001379:Azathioprine; D008727:Methotrexate